Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00136656Phase 4Completed
Phase 4, randomised, open-label trial of cefixime in acute pyelonephritis (2 arms), sponsored by Assistance publique - Hôpitaux de Paris. Primary endpoint: Renal scars on dimercaptosuccinic acid (DMSA) renal scan at 6 months. Started Jul 2005; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00136656.